If you wait for actual sales the pps will likely be substantially higher. Other catalysts exist to propel the stock higher. Successful completion of the safety study is a major milestone that could pave the way for a JV or licensing deal with a pharma company. We'd be looking at a pps in the multi dollar range potentially. No guts no glory man.